Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 558201 - 558220 out of 558221 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (C10AA05) atorvastatin (adm: O) | ATORVASTATIN CA 40MG TAB | 1000 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | RadhaPharmaceuticalsInc. |
| USA | (C10AA05) atorvastatin (adm: O) | ATORVASTATIN CA 80MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | RadhaPharmaceuticalsInc. |
| USA | (C10AA05) atorvastatin (adm: O) | ATORVASTATIN CA 80MG TAB | 500 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | RadhaPharmaceuticalsInc. |
| USA | (C10AB04) gemfibrozil (adm: O) | GEMFIBROZIL 600MG TAB | 500 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (C10AB04) gemfibrozil (adm: O) | GEMFIBROZIL 600MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (C10AB04) gemfibrozil (adm: O) | GEMFIBROZIL 600MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (C10AX) other lipid modifying agents | REDEMPLO 25MG/0.5ML INJ,SOLN SYR | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hyperlipoproteinemia Type I | ArrowheadPharmaceuticals,Inc. |
| USA | (C10AX) other lipid modifying agents | REDEMPLO 25MG/0.5ML INJ,SOLN SYR | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hyperlipoproteinemia Type I | ArrowheadPharmaceuticals,Inc. |
| USA | (C10AX12) lomitapide (adm: O) | JUXTAPID 2MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypercholesterolemia | ChiesiUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA 140MG/ML | 2X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA PUSHTRONEX 420MG/3.5ML | 3.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX13) evolocumab (adm: P) | REPATHA PUSHTRONEX 420MG/3.5ML | 3.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenUSA,Inc. |
| USA | (C10AX16) inclisiran (adm: P) | LEQVIO 284MG/1.5ML INJ | 1.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hypercholesterolemia;Dyslipidemias | NovartisPharmaceuticalsCorporation |
Pages
